551 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 12 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

F11Coagulation factor XICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
F2Coagulation factor II (thrombin)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
F2RCoagulation factor II (thrombin) receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
F5Coagulation factor V (proaccelerin, labile factor)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusGroup enriched
F8Coagulation factor VIII, procoagulant componentCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
FADS1Fatty acid desaturase 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FADS2Fatty acid desaturase 2Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FASNFatty acid synthaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Expressed in all
FCER1AFc fragment of IgE, high affinity I, receptor for; alpha polypeptideFDA approved drug targets
Predicted membrane proteins
Mixed
FCER1GFc fragment of IgE, high affinity I, receptor for; gamma polypeptideFDA approved drug targets
Predicted membrane proteins
Expressed in all
FCGR2AFc fragment of IgG, low affinity IIa, receptor (CD32)CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
FCGR2BFc fragment of IgG, low affinity IIb, receptor (CD32)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FDPSFarnesyl diphosphate synthaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FGF1Fibroblast growth factor 1 (acidic)Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmTissue enhanced
FGF2Fibroblast growth factor 2 (basic)Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleoplasm
Nuclear bodies
Mixed
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
NucleoliExpressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
VesiclesMixed
FGFR3Fibroblast growth factor receptor 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Endoplasmic reticulumTissue enriched
FGFR4Fibroblast growth factor receptor 4Cancer-related genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
FKBP1AFK506 binding protein 1A, 12kDaEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
MicrotubulesExpressed in all
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membrane
Actin filaments
Tissue enriched
FLT3Fms-related tyrosine kinase 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Endoplasmic reticulumTissue enhanced
FLT4Fms-related tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Nuclear speckles
Plasma membrane
Cell Junctions
Mixed
FN1Fibronectin 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
FOLH1Folate hydrolase (prostate-specific membrane antigen) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
FRKFyn-related Src family tyrosine kinaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Mixed
FTH1Ferritin, heavy polypeptide 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MicrotubulesExpressed in all
FTLFerritin, light polypeptideCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
FXYD2FXYD domain containing ion transport regulator 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
MitochondriaGroup enriched
GAAGlucosidase, alpha; acidDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
GABBR1Gamma-aminobutyric acid (GABA) B receptor, 1FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
CentrosomeTissue enhanced
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GABRA1Gamma-aminobutyric acid (GABA) A receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GABRA3Gamma-aminobutyric acid (GABA) A receptor, alpha 3FDA approved drug targets
Predicted membrane proteins
Tissue enriched
GABRA5Gamma-aminobutyric acid (GABA) A receptor, alpha 5FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Cell JunctionsTissue enriched
GABRA6Gamma-aminobutyric acid (GABA) A receptor, alpha 6FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
GABRB1Gamma-aminobutyric acid (GABA) A receptor, beta 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
GABRB2Gamma-aminobutyric acid (GABA) A receptor, beta 2FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GABRDGamma-aminobutyric acid (GABA) A receptor, deltaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Golgi apparatus
Vesicles
Tissue enriched
GABREGamma-aminobutyric acid (GABA) A receptor, epsilonFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GABRG1Gamma-aminobutyric acid (GABA) A receptor, gamma 1FDA approved drug targets
Predicted membrane proteins
Tissue enriched
GABRG3Gamma-aminobutyric acid (GABA) A receptor, gamma 3FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
GABRPGamma-aminobutyric acid (GABA) A receptor, piFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
GABRQGamma-aminobutyric acid (GABA) A receptor, thetaFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GAMTGuanidinoacetate N-methyltransferaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
GANABGlucosidase, alpha; neutral ABEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nuclear membrane
Endoplasmic reticulum
Cytosol
Expressed in all
GANCGlucosidase, alpha; neutral CEnzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Actin filaments
Expressed in all
GARTPhosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Mitochondria
Cytosol
Expressed in all

« prev | Page of 12 | next »